John is working with Socrates as a 3rd party consultant working closely with the R&D team on development,
design, experiments and clinical studies to assist in measuring the accuracy and robustness of the device.
He is the resident expert on clinical knowledge for the product providing support to the product development
team during R&D, Design, Engineering and Manufacturing. He will be critical in setting up the Socrates regulatory
team who will be responsible for all regulatory submissions and clinical trials worldwide as well as
quality activities across multiple R&D partners and manufacturing facilities to comply with the
FDA regulations and guidelines.
John has more than 25 years of experience developing and commercializing noninvasive medical diagnostic devices based on visible, fluorescence, near infrared, Raman, and infrared imaging and spectroscopy. He has an active consulting practice in U.S. and international medical device product development, clinical trials, regulatory affairs, quality management systems, product management and business development. John was a co-founder and executive vice president of VeraLight which commercialized SCOUT DS, a noninvasive diabetes screening device based on skin fluorescence multivariate spectroscopy. Prior to VeraLight, John was a co-founder and vice president of engineering of InLight Solutions. InLight had a 10-year strategic partnership with the LifeScan division of Johnson & Johnson to develop noninvasive a glucose measurement device based on near infrared spectroscopy. John graduated from Stanford University in 1987 with a master's degree in electrical engineering. He holds 19 U.S. patents and has published 27 peer-reviewed journal articles related to diabetes and its complications.